HomeHealthcare & Life SciencesPharmaceuticals Metformin Hydrochloride Market

Middle East And Africa Metformin Hydrochloride Market Size & Outlook, 2025-2033


Middle East And Africa Metformin Hydrochloride Market Insights

  • As per Reed Intelligence insights, Middle East And Africa’s Metformin Hydrochloride Market was valued at USD 1717.14 Million in 2024 and is anticipated to expand to USD 3256.51 Million by 2033.
  • From 2026 to 2033, the market is anticipated to expand at a CAGR of 7.44%.
  • Within By Indication, Type 2 Diabetes accounted for the largest market size in 2024.
  • During the forecast period, Polycystic Ovary Syndrome is anticipated to remain the highest-growth segment within the By Indication category.

Other Key Findings


  • Middle East And Africa held 8.56% share of the global Metformin Hydrochloride Market size in 2024.
  • United States is expected to remain the largest contributor to the global market size by 2033.
  • By 2033, Egypt is anticipated to record the highest growth in Middle East and Africa, with the market size expected to reach USD 365.72 Million.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 1717.14 Million
Market Size In 2033 USD 3256.51 Million
Largest segment Type 2 Diabetes
Units Revenue in USD Million
CAGR 7.44% (2025-2033)
Segmnetation Covered
Middle East and Africa
  1. United Arab Emirates
  2. Saudi Arabia
  3. South Africa
  4. Egypt
  5. Nigeria
  6. Turkey
By Indication
  1. Type 2 Diabetes
  2. Gestational Diabetes
  3. Polycystic Ovary Syndrome
Form
  1. Tablets
  2. Extended-Release Tablets
  3. Oral Solutions
  4. Injectable Solutions
Route of Administration
  1. Oral
  2. Intravenous
Distribution Channel
  1. Retail Pharmacies
  2. Hospital Pharmacies
  3. Online Pharmacies
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports